医学
狼疮性肾炎
环磷酰胺
免疫抑制
内科学
系统性红斑狼疮
不利影响
胃肠病学
免疫学
化疗
疾病
标识
DOI:10.1016/j.ekir.2022.01.518
摘要
Lupus nephritis (LN)is classified histologically according to the International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification. Within this classification class III and IV LN have the worst prognosis and warrant intense immunosuppression with potential for more severe adverse effects. . The first line treatment for class III and IV LN in our setting is low-dose intravenous cyclophosphamide as per the Eurolupus protocol(CYC). The purpose of this study was to identify clinicopathological features at presentation which would correlate with response to treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI